London (IT Boltwise) – A significant progress in the treatment of cystic fibrosis promises to significantly extend the life expectancy of the patients. The drug trikafta, developed by leading scientists, has the potential to drastically improve the quality of life of those affected and has been awarded the renowned Lasker-Debakey Clinical Medical Research Award.
Today’s daily deals on Amazon! ˗ˋˏ$ˎˊ˗
The development of the drug trikafta marks significant progress in the treatment of cystic fibrosis, a genetic disease caused by mutations in the CFTR gene. These mutations lead to a malfunction of the ion channels in the cell membranes, which leads to an accumulation of thick mucus in the organs. Trikafta aims to fix this molecular cause and has the potential to extend the life expectancy of the patients by decades.
The researchers Dr. Michael Welsh, Paul Negulescu and Jesús Gonzáles were awarded the Lasker-Debakey Clinical Medical Research Award for their groundbreaking work. Her research has shown that treatment with trikafta significantly improves the quality of life of people with cystic fibrosis by restoring the function of ion channels and thus relieving the symptoms of the disease.
TRIKAFTA combines three medications that work together to correct the most common genetic defects in cystic fibrosis. This combination has proven to be extremely effective and leads to a significant reduction in lung infections and the need for lung transplants. Treatment is particularly effective when it begins in childhood or adolescence, which enables patients to expect almost normal life expectancy.
The recognition by the Lasker Award underlines the importance of this development for medical research and the treatment of genetic diseases. The researchers hope that their work not only improves the lives of people with cystic fibrosis, but also paving their way for further progress in gene therapy.
*Order Amazon credit card without an annual fee with 2,000 euros! a‿z
Bestseller no. 1 ᵃ⤻ᶻ “Ki Gadgets”
Bestseller no. 2 ᵃ⤻ᶻ “Ki gadgets”
Bestseller no. 3 ᵃ⤻ᶻ “Ki gadgets”
Bestseller no. 4 ᵃ⤻ᶻ “Ki gadgets”
Bestseller no. 5 ᵃ⤻ᶻ “Ki Gadgets”
Additions and information to the editorial team by email to DE-Info[at]it-boltwise.de. Since we cannot rule out rarely occurring AI Hallucinations in the event of AI generated news and content, we ask you to contact and inform us for false information and misinformation via email. Please do not forget to name the article headline in the email: “Throughout the treatment of cystic fibrosis: trikafta extended life expectancy”.
